NCT00049517 2023-06-15
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Eastern Cooperative Oncology Group
Phase 3 Completed
Clinical Trials
7 trialsNCT00372593 2021-03-24
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
Children's Oncology Group
Phase 3 Completed
NCT00860639 2017-01-27
LAM2006IR
Nantes University Hospital
Phase 3 Completed
NCT00476541 2016-05-13
NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia
University of Aarhus
Phase 3 Completed
NCT00136084 2012-12-05
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
St. Jude Children's Research Hospital
Phase 3 Completed
NCT00052299 2012-08-27
AML-17
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00962767 2009-08-20
Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3 Completed